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Background: 
 
Optimal stent deployment is an essential predictor of success
in patients with coronary artery stenosis treated by percutaneous coronary
intervention (PCI). 
 
Objectives:
 
 We sought to analyze stent deployment in long lesions treated
with drug eluting stent (DES) using intravascular ultrasound imaging (IVUS)
techniques.
 
Methods:
 
 N=27 patients were treated for long (> 28 mm) coronary artery
stenosis. The culprit lesion was analyzed by conventional angiography, then
treated by PCI including DES implantation. Post implantation IVUS was per-
formed to assess stent deployment using MUSIC and AVIO criteria. Elective
post-dilation balloon inflation was performed at the discretion of the physician.
 
Results:
 
 N=38 DES were implanted in N=27 lesions (mean
length:33.3±8.5 mm ), including n=7 right coronary (RCA) , n= 16 left ante-
rior descending (LAD) and n=4 circumflex (Cx) arteries. We observed pro-
gressive narrowing along the LAD and Cx lesions: there was a significant
(p<0.05) decrease in artery diameter (LAD: -0.9±0.4 mm, Cx: -1.6±0.7 mm)
and external elastic membrane cross sectional area (EEM-CSA/ LAD: -
5.04±2.9 mm2, Cx: -8.64±4.7 mm2) between proximal and distal stent edges.
These differences were not observed in RCA. The reduction in arterial dimen-
sions was related to bifurcations and side branches presence: the loss of EEM-
CSA and diameter in main branch was correlated to the sum of the side
branches diameters (respectively r=0.62 and r=0.53, p<0.01). 
After stent implantation, sub-optimal deployment was observed in 60 % of
cases using the MUSIC criteria and 38% using the AVIO criteria. IVUS
guided post-dilation was performed in 89 % of the cases, resulting in a mean
main luminal area gain (MLA gain) of 1.9±1.5 mm2. Multivariate analysis
showed that EEM-CSA was the single independent predictor of MLA gain.
 
Conclusion:
 
 DES implantation in long lesions results frequently in subop-
timal deployment. IVUS analysis could help improving PCI quality, although
the current criteria for correct implantation should be modified to consider
changes in diameters observed along long coronary stenosis, due to presence
of bifurcations and side branches.
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Background: 
 
Diffusion weighted magnetic resonance imaging (DWI) is
used to identify tissue injury area in patients admitted for stroke. Limited study
has been performed to evaluate its clinical interest in patients with acute ST
elevation myocardial infarction (STEMI).
 
Methods: 
 
The study included 17 patients (14 men, 55±14years, 12 ante-
rior) with a recent STEMI (<7 days) treated by percutaneous coronary inter-
vention. A breath free ECG gated DWI sequence with increasing b values (0,
50, 100, 150 and 200 sec/mm
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) was applied in attempting to image myocardial
injury. Hypersignal area was automatically computed from log transformed
DWI sequences. The hypersignal area was compared to baseline (n=17) and
left ventricular ejection fraction (LVEF) recovery (n=11).
 
Results: 
 
Large area of hypersignal correlated with impaired baseline
LVEF whatever b value (r value range between 0.58 and 0.60, p<0.05 for all).
However, only hypersignal area with b=50 sec/mm
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 correlated with LVEF
recovery (r=-0.61, p < 0.05). Importantly, apparent diffusion coefficient failed
to correlate with baseline and LVEF recovery.
 
Conclusion: 
 
In patients with acute MI, hypersignal area from diffusion
weighted magnetic resonance imaging with b=50 sec/mm
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 seems to provide an
accurate assessment of myocardial injury and may be used to predict LVEF
recovery.
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Aims:
 
 Natural history and prognosis of ACS in HIV-infected patients
remain to be determined. The aim of our study was to compare coronary risk
factors, angiographic features, acute results of PCI, in-hospital outcomes, and
prespecified 1and 3-year prognosis of HIV-infected and HIV-uninfected
patients with ACS. 
 
Methods and results:
 
 HIV-infected and HIV-uninfected patients with a first
episode of ACS were matched for age (± 5 years), sex, and type of ACS. The pri-
mary endpoint was the rate of major adverse cardiac and cerebral events
(MACCE), comprising cardiac death, recurrent ACS, recurrent coronary revascu-
larization, and stroke. Overall 103 HIV-infected and 195 HIV-uninfected patients
were enrolled (mean age 49.0 ± 9.4 years, 94% men). Coronary risk factors were
well balanced, but HIV-infected patients more frequently used illicit drugs (23%
vs 6%, 
 
P
 
 = 0.001) and had higher triglyceride level (246±189 vs 170±139 mg/dl,
 
P
 
 = 0.002) compared with HIV-uninfected patients. Angiographic features of
CAD was similar (multivessel disease 41% vs 39%, p = 0.96; ACC/AHA type cul-
prit lesion 
 
≥
 
B2, both 77%, 
 
P
 
 = 0.83). At 1 year, the rate of occurrence of first
MACCE did not differ between groups (hazard ratio [HR:] 1.4; 95% CI: 0.6 to
3.0). Recurrent ACS was more frequent in HIV-infected patients (HR: 4.6; 95%
CI: 1.4 to 15.0) with no difference in the rate of clinical restenosis. 
 
Conclusion:
 
 These results suggest that acute management of ACS in HIV-
infected patients can routinely be the same as that of HIV-uninfected patients
but that specific secondary prevention measures are needed to alleviate this
increased risk of recurrent ACS. The 3-year follow up will be obtained and
analyzed before the end of 2010.
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Background:
 
 Fetuin-A is an ubiquitary anti-inflammatory protein that
counteracts CRP effects and has a protective effect against inflammation and
myocardial ischemia. Low fetuin-A has been found to be associated with car-
diovascular death in patients with end-stage renal failure disease. Low fetuin-
A combined with high CRP level may be used to severe inflammatory imbal-
ance and to predict outcome in acute coronary syndromes (ACS). 
 
Methods:
 
 We measured admission plasma fetuin-A and CRP level in 748
consecutive patients (65±13 years, sex, 389 with ST and 337 without ST ele-
vation) included in the ACS French registry (Fast MI) and correlated these
data with the outcome. Tertile was used to define low fetuin-A (tertile 1) and
